If you are an API manufacturer dealing with clogging in continuous flow systems—this project developed liquid-tube technology that handles solids without clogging. This allows you to shift from batch to continuous processes for organometallic chemistry, reducing production costs and industrial footprint.
Clog-Free Continuous Flow Reactors for Pharmaceutical and Fine Chemical Production
Imagine trying to push a thick smoothie through a thin straw; it often gets stuck and blocks the flow. This technology replaces the solid straw walls with a special liquid layer that lets particles slide through without sticking. It allows chemical factories to run their production like a continuous assembly line instead of making one batch at a time.
What needed solving
Current continuous flow systems clog when handling solids or viscous liquids, limiting their use to only 33% of chemical processes. This forces companies to rely on inefficient, less safe, and larger-footprint batch processing.
What was built
A proprietary continuous flow reactor featuring liquid walls (liquid-tube technology) that prevents clogging and friction while handling solids.
Who needs this
Who can put this to work
If you are a specialty chemical producer dealing with safety and quality concerns in batch processing—this project developed a non-clogging flow reactor that increases efficiency and yields. It enables the use of processes that were previously impossible in flow due to solid particles.
If you are a consultant dealing with the limitation that only 33% of chemical processes can be conducted in continuous flow—this project developed a proprietary liquid wall reactor. This tool enables the industrial scale-up of previously impossible chemical reactions.
Quick answers
How does this affect production costs?
Based on available project data, the shift from batch to continuous processes using this technology leads to reduced production costs and a smaller environmental footprint.
Can this technology be used at an industrial scale?
Yes, the project aims to industrialize the liquid tube flow reactors and provide modular solutions for both research and industrial scale applications.
What is the IP status of the technology?
The technology is proprietary and a Freedom to Operate (FTO) analysis confirmed there are no competitive patents in the landscape, making its positioning disruptive.
What specific chemical processes are being targeted?
The project is focusing on organometallic chemistry, specifically processes that were previously impossible in continuous flow due to clogging.
What is the expected timeline for market availability?
The project period runs from 2024-03-01 to 2026-12-31, during which the company is industrializing the reactors for market release.
Who built it
The project is led by a single French SME, QFLUIDICS, which holds 100% of the industry ratio. This lean structure suggests a fast-track commercialization approach where the company maintains full control over the proprietary IP and industrialization process.
Contact QFLUIDICS in France regarding their liquid-tube reactor modular solutions.
Talk to the team behind this work.
Contact us to explore licensing or partnership opportunities with QFLUIDICS.